Doctors urged to screen for metabolic fatty liver
Microbiome Diversity

Doctors urged to screen for metabolic fatty liver

By Samoyed · 346 Views · October 27, 2026
Recovery Modalities

Three biotech firms eye Nasdaq listings

Three biotech firms—including ADARx Pharma—are preparing Nasdaq listings, with ADARx targeting a $1.74 billion valuation for its hereditary...

September 22, 2026

Editor's picks

All Post

Nutrient Synergy

In-Depth Analysis Pharmacy Landscape in Indonesia

The pharmacy sector in Indonesia plays a crucial role in the nation’s healthcare system. As one of the largest countries in Southeast Asia, Indonesia’s diverse population and expansive geography present unique challenges and opportunities for...

Samoyed 211 Views August 27, 2026